drugset
drugset / Trial / NCT01549743

The Pharmacokinetic Interaction Between Celecoxib and Rebamipide

NCT01549743 ↗

Phase 1 Completed 30 enrolled Hanlim Pharm. Co., Ltd.
RandomizedCrossoverOpen-labelOther

Summary

This clinical trial aims to assess the pharmacokinetic interaction between celecoxib and rebamipide in healthy male subjects.

Timeline

Start
2012-05-09
Primary completion
2012-06-13
Completion
2012-06-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg Oral
Subject Rebamipide Small molecule 100 mg Oral

Indications

No indication recorded.